Upgrade to SI Premium - Free Trial

Eli Lilly & Co. (LLY) said one of its antibody therapies could be authorized for COVID-19 treatment as early as September - Reuters

June 10, 2020 3:40 PM
Eli Lilly & Co. (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Trader Talk